Pecularities of drug therapy of coronary artery disease in combination with postmenopausal osteoporosis

Abstract

Aim of the study. To evaluate the clinical effectiveness of the supplementary inclusion of a combination of sodium alendronate and L-arginine hydrochloride to a basic treatment in women with coronary artery disease (CAD) comorbid with postmenopausal osteoporosis (PMOP).